An Efficacy and Safety Comparison Study of Two Marketed Drugs in Patients With Relapsing-remitting MS

NCT00206648 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

271

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis, Relapsing-Remitting

Interventions

DRUG: Betaferon/Betaseron
DRUG: Betaferon/Betaseron

Sponsor

Bayer